{
  "questions": [
    {
      "topic": "Cytogenetics of Cancer",
      "subtopic": "Oncogenic Translocations",
      "slide_ref": 2,
      "stem": "t(9;22) in CML creates:",
      "options": [
        "PML-RARA",
        "MYC-IGH",
        "BCR-ABL1",
        "ETV6-RUNX1",
        "EWS-FLI1"
      ],
      "answer": "BCR-ABL1",
      "explanation": "Philadelphia chromosome TK fusion.",
      "difficulty": "hard",
      "image": "sandbox:/mnt/data/Master_Qbank_All/Cytogenetics_of_Cancer/slide02.png"
    },
    {
      "topic": "Cytogenetics of Cancer",
      "subtopic": "Lymphoma",
      "slide_ref": 3,
      "stem": "t(14;18) overexpresses:",
      "options": [
        "Cyclin D1",
        "BCL2",
        "MYC",
        "BCL6",
        "PAX5"
      ],
      "answer": "BCL2",
      "explanation": "IGH enhancer drives BCL2.",
      "difficulty": "hard",
      "image": "sandbox:/mnt/data/Master_Qbank_All/Cytogenetics_of_Cancer/slide03.png"
    },
    {
      "topic": "Cytogenetics of Cancer",
      "subtopic": "Ewing",
      "slide_ref": 4,
      "stem": "Classic Ewing sarcoma translocation:",
      "options": [
        "t(15;17)",
        "t(11;22)",
        "t(8;14)",
        "t(2;5)",
        "t(3;14)"
      ],
      "answer": "t(11;22)",
      "explanation": "EWSR1-FLI1 fusion.",
      "difficulty": "hard",
      "image": "sandbox:/mnt/data/Master_Qbank_All/Cytogenetics_of_Cancer/slide04.png"
    },
    {
      "topic": "Cytogenetics of Cancer",
      "subtopic": "APL",
      "slide_ref": 5,
      "stem": "t(15;17) AML best initial therapy:",
      "options": [
        "ATRA \u00b1 ATO",
        "Imatinib",
        "Rituximab",
        "Trastuzumab",
        "Bevacizumab"
      ],
      "answer": "ATRA \u00b1 ATO",
      "explanation": "Treat PML-RARA APL with ATRA/ATO.",
      "difficulty": "hard",
      "image": "sandbox:/mnt/data/Master_Qbank_All/Cytogenetics_of_Cancer/slide05.png"
    },
    {
      "topic": "Cytogenetics of Cancer",
      "subtopic": "HER2",
      "slide_ref": 6,
      "stem": "Confirm HER2 amplification with:",
      "options": [
        "Karyotype",
        "Sanger",
        "FISH HER2/CEP17 ratio",
        "Southern",
        "MSP"
      ],
      "answer": "FISH HER2/CEP17 ratio",
      "explanation": "Clinical HER2 assessment often uses ratios.",
      "difficulty": "hard",
      "image": "sandbox:/mnt/data/Master_Qbank_All/Cytogenetics_of_Cancer/slide06.png"
    }
  ]
}